336 related articles for article (PubMed ID: 7815548)
1. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.
Steinkasserer A; Harrison R; Billich A; Hammerschmid F; Werner G; Wolff B; Peichl P; Palfi G; Schnitzel W; Mlynar E
J Virol; 1995 Feb; 69(2):814-24. PubMed ID: 7815548
[TBL] [Abstract][Full Text] [Related]
2. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions.
Billich A; Hammerschmid F; Peichl P; Wenger R; Zenke G; Quesniaux V; Rosenwirth B
J Virol; 1995 Apr; 69(4):2451-61. PubMed ID: 7884893
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog.
Rosenwirth B; Billich A; Datema R; Donatsch P; Hammerschmid F; Harrison R; Hiestand P; Jaksche H; Mayer P; Peichl P
Antimicrob Agents Chemother; 1994 Aug; 38(8):1763-72. PubMed ID: 7527198
[TBL] [Abstract][Full Text] [Related]
4. The non-immunosuppressive cyclosporin A analogue SDZ NIM 811 inhibits cyclophilin A incorporation into virions and virus replication in human immunodeficiency virus type 1-infected primary and growth-arrested T cells.
Mlynar E; Bevec D; Billich A; Rosenwirth B; Steinkasserer A
J Gen Virol; 1997 Apr; 78 ( Pt 4)():825-35. PubMed ID: 9129655
[TBL] [Abstract][Full Text] [Related]
5. The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811.
Dorfman T; Göttlinger HG
J Virol; 1996 Sep; 70(9):5751-7. PubMed ID: 8709190
[TBL] [Abstract][Full Text] [Related]
6. Unintegrated HIV-1 circular 2-LTR proviral DNA as a marker of recently infected cells: relative effect of recombinant CD4, zidovudine, and saquinavir in vitro.
Panther LA; Coombs RW; Aung SA; dela Rosa C; Gretch D; Corey L
J Med Virol; 1999 Jun; 58(2):165-73. PubMed ID: 10335865
[TBL] [Abstract][Full Text] [Related]
7. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.
Dubrovsky L; Ulrich P; Nuovo GJ; Manogue KR; Cerami A; Bukrinsky M
Mol Med; 1995 Jan; 1(2):217-30. PubMed ID: 8529100
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase.
Nagy K; Young M; Baboonian C; Merson J; Whittle P; Oroszlan S
J Virol; 1994 Feb; 68(2):757-65. PubMed ID: 8289379
[TBL] [Abstract][Full Text] [Related]
9. Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions.
Svarovskaia ES; Barr R; Zhang X; Pais GC; Marchand C; Pommier Y; Burke TR; Pathak VK
J Virol; 2004 Apr; 78(7):3210-22. PubMed ID: 15016842
[TBL] [Abstract][Full Text] [Related]
10. Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages.
Perez-Bercoff D; David A; Sudry H; Barré-Sinoussi F; Pancino G
J Virol; 2003 Apr; 77(7):4081-94. PubMed ID: 12634367
[TBL] [Abstract][Full Text] [Related]
11. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.
D'Aloja P; Olivetta E; Bona R; Nappi F; Pedacchia D; Pugliese K; Ferrari G; Verani P; Federico M
J Virol; 1998 May; 72(5):4308-19. PubMed ID: 9557721
[TBL] [Abstract][Full Text] [Related]
12. The tripeptide glycyl-prolyl-glycine amide does not affect the early steps of the human immunodeficiency virus type 1 replication.
Su J; Naghavi MH; Jejcic A; Horal P; Furuta Y; Wu YP; Li SL; Hall WW; Goobar-Larsson L; Svennerholm B; Vahlne A
J Hum Virol; 2001; 4(1):8-15. PubMed ID: 11213934
[TBL] [Abstract][Full Text] [Related]
13. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines.
Brack-Werner R; Kleinschmidt A; Ludvigsen A; Mellert W; Neumann M; Herrmann R; Khim MC; Burny A; Müller-Lantzsch N; Stavrou D
AIDS; 1992 Mar; 6(3):273-85. PubMed ID: 1373627
[TBL] [Abstract][Full Text] [Related]
14. Effect of cyclosporin A on the replication cycle of human immunodeficiency virus type 1 derived from H9 and Molt-4 producer cells.
Briggs CJ; Tözsér J; Oroszlan S
J Gen Virol; 1996 Dec; 77 ( Pt 12)():2963-7. PubMed ID: 9000086
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human immunodeficiency virus type 1 replication in acutely and chronically infected cells by EM2487, a novel substance produced by a Streptomyces species.
Baba M; Okamoto M; Takeuchi H
Antimicrob Agents Chemother; 1999 Oct; 43(10):2350-5. PubMed ID: 10508005
[TBL] [Abstract][Full Text] [Related]
16. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.
Ojwang JO; Buckheit RW; Pommier Y; Mazumder A; De Vreese K; Esté JA; Reymen D; Pallansch LA; Lackman-Smith C; Wallace TL
Antimicrob Agents Chemother; 1995 Nov; 39(11):2426-35. PubMed ID: 8585721
[TBL] [Abstract][Full Text] [Related]
17. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro.
Montaner LJ; Griffin P; Gordon S
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3393-400. PubMed ID: 7527834
[TBL] [Abstract][Full Text] [Related]
19. Cyclophilin a modulates processing of human immunodeficiency virus type 1 p55Gag: mechanism for antiviral effects of cyclosporin A.
Streblow DN; Kitabwalla M; Malkovsky M; Pauza CD
Virology; 1998 Jun; 245(2):197-202. PubMed ID: 9636359
[TBL] [Abstract][Full Text] [Related]
20. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
Chen H; He J; Fong S; Wilcox G; Wood C
J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
